Study of Avelumab in Combination With Lenvatinib for Children With Primary CNS Tumors
Condition: Central Nervous System Tumors Interventions: Drug: Avelumab; Drug: Lenvatinib Sponsors: EMD Serono Research & Development Institute, Inc.; Merck KGaA, Darmstadt, Germany Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials